1. DDDR-23. IN SILICO DRUG DISCOVERY REVEALS SUBTYPE-SPECIFIC COMBINATION THERAPIES WITH CASEIN KINASE 2 INHIBITOR CX-4945 IN GLIOBLASTOMA. (14th November 2022) Authors: Ayad, Nagi; Suter, Robert; Jermakowicz, Anna; Kaeppeli, Simon Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EPCO-14. ISOSCELES: AN INTEGRATIVE FRAMEWORK FOR THE PREDICTION OF TREATMENT RESISTANT GLIOBLASTOMA CELLS. (14th November 2022) Authors: Suter, Robert; Jermakowicz, Anna; Stathias, Vasileios; Ruiz, Luz; D'Antuono, Matthew; Kaeppeli, Simon; Baker, Grace; Veeramachaneni, Rithvik; Walters, Winston; Cepero, Maria; Williams, Sion; Ivan, Michael; Komotar, Ricardo; De La Fuente, Macarena; Sarkaria, Jann; Schürer, Stephan; Ayad, Nagi Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗